logo

Seres Therapeutics, Inc. (MCRB)



Trade MCRB now with
  Date
  Headline
5/9/2018 7:13:00 AM Seres Therapeutics Q1 Net Loss Widens To $27.9 Mln From $25.5 Mln Last Year
3/14/2018 7:07:43 AM Flagship Pioneering Launches Foghorn Therapeutics With Initial Capital Commitment Of $50 Mln
3/8/2018 7:11:21 AM Seres Therapeutics Q4 Net Loss Widens To $29.0 Mln From $25.3 Mln Last Year
1/31/2018 7:08:01 AM Seres Therapeutics Unveils Appointment Of Eric Shaff To Addl. Role Of COO
3/30/2016 8:30:09 AM FBR Capital Markets Starts Seres Therapeutics, Inc. (MCRB) At Outperform With $40 Price Target